11 Dec, 2025
\n \n \n \n\n \n \n9 Dec, 2025
\n \n \n \nScientists at the Centre for Medicines Discovery, part of Oxford University\u2019s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.
\n \n\n \n \n16 Sep, 2025
\n \n \n \nDr. Yi-Ling Chen, COI Career Development Fellow, awarded a prestigious ERC Starting Grant to Investigate the Role of CD1c-reactive T Cells in Post-streptococcal Disease. The ERC Starting Grant supports early-career researchers with 2-7 years of experience since completion of their PhD, providing up to \u20ac1.5 million over five years to establish independent research teams and pursue high-risk, high-reward science.
\n \n\n \n \n18 Oct, 2024
\n \n \n \nOn Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M\u2122 malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country\u2019s fight against the deadly disease.
\n \n\n \n \n10 Sep, 2024
\n \n \n \nScientists from the Centre for Human Genetics at Nuffield Department of Medicine are taking the initial steps in developing the UK\u2019s first vaccine to prevent cancer in people with Lynch syndrome, thanks to funding from Cancer Research UK.
\n \n\n \n \n12 Aug, 2024
\n \n \n \nThe Pandemic Sciences Institute, in collaboration with the Ethox Centre, has supported a new exhibition at Oxford\u2019s History of Science Museum. The exhibition, entitled \"A Healthy Future for All?\", explores the science driving advancements in healthcare
\n \n\n \n \n16 Jul, 2024
\n \n \n \nC\u00f4te d\u2019Ivoire will become the first country to roll-out the new R21/Matrix-M\u2122 vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.
\n \n\n \n \n6 Jun, 2024
\n \n \n \nMany congratulations to Dr Caesar Atuire who has been appointed President of the International Association of Bioethics.
\n \n\n \n \n27 May, 2024
\n \n \n \nThe Minister of Health and Family Welfare of Bangladesh, the Honourable Dr Samanta Lal Sen, and the Bangladesh High Commissioner to the UK, Her Excellency Ms Saida Muna Tasneem, paid a visit to the Centre for Medicines Discovery at NDM last week.
\n \n\n \n \n23 May, 2024
\n \n \n \nResearchers from the Pandemic Sciences Institute at NDM are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
\n \n\n \n \n21 May, 2024
\n \n \n \nThe Academy of Medical Sciences has elected two medical scientists from the Nuffield Department of Medicine to its fellowship in 2024.
\n \n\n \n \n16 May, 2024
\n \n \n \nTwo academics from the Nuffield Department of Medicine have joined the Royal Society as Fellows.
\n \n\n \n \n3 May, 2024
\n \n \n \nProfessor Yang Shi from the Ludwig Institute for Cancer Research at NDM has been elected as a member of the National Academy of Sciences in the United States.
\n \n\n \n \n2 May, 2024
\n \n \n \nFor Skin Cancer Awareness Month, the Ludwig Institute for Cancer Research looks at recent research into melanoma from Professors Richard White, Professor of Genetics, and Colin Goding, Professor of Oncology.
\n \n\n \n \n30 Apr, 2024
\n \n \n \nThe Oxford immunology community celebrated the donation of Sir Peter Medawar\u2019s Nobel Prize medal to the University.
\n \n\n \n \n29 Apr, 2024
\n \n \n \nA randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
\n \n\n \n \n25 Apr, 2024
\n \n \n \nResearchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.
\n \n\n \n \n15 Apr, 2024
\n \n \n \nThe Chinese Ambassador to the United Kingdom, His Excellency Zheng Zeguang, visited the University of Oxford last week, where he promoted deeper educational exchanges between China and the UK. During the visit, Zheng met with Irene Tracey, Vice-Chancellor of the university, and had an in-depth discussion on the university\u2019s collaboration with Chinese counterparts.
\n \n\n \n \n8 Apr, 2024
\n \n \n \nDr Francesco Boccellato, Leadership Fellow at the Oxford Branch of the Ludwig Institute for Cancer Research has recently been awarded the Lee Placito Research Fellowship in Gastrointestinal Cancer.
\n \n\n \n \n5 Apr, 2024
\n \n \n \nResearchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
\n \n\n \n \n